Amarin Corp Plc News, Amarin Corp Plc Quote, AMRN Quote

Amarin Corp Plc (NQ:AMRN) Delayed: 6.60 -0.02 (0.3%)	Trade Now!
Previous Close	$6.62	52 Week High	$15.96
Open	$6.57	52 Week Low	$6.25
Day High	$6.72	P/E	N/A
Day Low	$6.50	EPS	$0.00
Volume	1,685

Jun 18, 2013 12:13 PM Amarin (AMRN) NCE Delay Not all Negative - MKM Partners
Jun 14, 2013 02:08 PM Amarin (AMRN) Vascepa NCE Not in Latest FDA Orange Book Update
Jun 6, 2013 08:20 AM Amarin (AMRN) Up as Vascepa Shows Strong Rx Growth Last Week
Jun 4, 2013 10:50 AM Bontan closes Portage Pharma Limited acquisition
May 30, 2013 04:05 PM Amarin to Present at the Jefferies 2013 Global Healthcare Conference
May 30, 2013 09:29 AM StreetInsider.com Pre-Open Movers 5/30: (NVE) (CLWR) (EXPR) Higher; (ABIO) (BIG) (BWP) Lower (more...)
May 30, 2013 06:53 AM Elan's (ELN) Ingram: Amarin (AMRN), Vascepa Still an Opportunity We're Considering
May 30, 2013 06:40 AM Amarin (AMRN) Reports Significant Additional Data from Vascepa Phase 3 ANCHOR
May 30, 2013 06:00 AM Amarin Announces Additional Effects of Vascepa(R) on Lipoprotein Particle Concentration From the ANCHOR Study Presented at the National Lipid Association 2013 Annual Scientific Sessions
May 29, 2013 04:31 PM Form 4 AMARIN CORP PLC\UK For: May 29 Filed by: THERO JOHN F

May 9, 2013 04:14 PM Amarin Corp Plc (AMRN) Posts Q1 Loss of 41c/Share
Feb 28, 2013 04:03 PM Amarin Corp Plc (AMRN) Reports In-Line Q4 Loss of 28c/Share
Nov 8, 2012 04:29 PM Amarin Corp Plc (AMRN) Posts Q3 adj.Loss of 26c/Share; Updates on Vascepa Approvals, Exclusivity
Sep 10, 2012 05:10 PM Amarin (AMRN) Said No FDA NCE Decision in August Orange Book
Aug 17, 2012 09:34 AM Amarin (AMRN) Discloses Delay in Vascepa NCE Status
Aug 8, 2012 04:02 PM Amarin Corp Plc (AMRN) Posts Q2 Loss of 20c/Share, Wider than Views
Jul 26, 2012 05:44 PM Amarin (AMRN) Wins FDA Approval of Vascepa
May 8, 2012 04:03 PM Amarin Corp Plc (AMRN) Misses Q1 EPS by 3c
Mar 20, 2012 11:46 AM USPTO Allows Amarin's (AMRN) '598 Application, Investors Cheer
Feb 29, 2012 04:03 PM Amarin Corp Plc (AMRN) Reports Q4 Loss of $0.08

Jun 18, 2013 12:13 PM Amarin (AMRN) NCE Delay Not all Negative - MKM Partners
Jun 14, 2013 02:08 PM Amarin (AMRN) Vascepa NCE Not in Latest FDA Orange Book Update
Jun 6, 2013 08:20 AM Amarin (AMRN) Up as Vascepa Shows Strong Rx Growth Last Week
May 30, 2013 09:29 AM StreetInsider.com Pre-Open Movers 5/30: (NVE) (CLWR) (EXPR) Higher; (ABIO) (BIG) (BWP) Lower (more...)
May 30, 2013 06:53 AM Elan's (ELN) Ingram: Amarin (AMRN), Vascepa Still an Opportunity We're Considering
May 30, 2013 06:40 AM Amarin (AMRN) Reports Significant Additional Data from Vascepa Phase 3 ANCHOR
May 28, 2013 02:23 PM Notable 52-Week Highs and Lows of the Day 05/28: (CPST) (CSIQ) (PIP) High; (AGNC) (AMRN) (GNVC) Low
May 28, 2013 12:28 PM Amarin (AMRN) Slumps as Role of Vascepa Downplayed
May 28, 2013 07:42 AM Amarin (AMRN) Sees Upside After AstraZeneca Scoops-Up Omthera (OMTH)
May 17, 2013 02:32 PM Amarin's (AMRN) Vascepa Not in FDA Orange Book for April

Jun 4, 2013 10:50 AM Bontan closes Portage Pharma Limited acquisition
May 30, 2013 04:05 PM Amarin to Present at the Jefferies 2013 Global Healthcare Conference
May 30, 2013 06:00 AM Amarin Announces Additional Effects of Vascepa(R) on Lipoprotein Particle Concentration From the ANCHOR Study Presented at the National Lipid Association 2013 Annual Scientific Sessions
May 22, 2013 06:00 AM Amarin Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa(R) and Statin Therapy
May 9, 2013 04:05 PM Photo Release -- Amarin Reports First Quarter 2013 Financial Results and Provides Update on Operations
May 3, 2013 04:00 PM Amarin to Report First Quarter 2013 Results and Host Conference Call on May 9, 2013
Apr 30, 2013 06:00 AM Amarin Announces Approval of Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
Apr 23, 2013 06:00 AM Amarin Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for Vascepa(R) for the Treatment of Patients With High Triglycerides (>200 mg/dL and <500 mg/dL) With Mixed Dyslipidem

May 29, 2013 04:31 PM Form 4 AMARIN CORP PLC\UK For: May 29 Filed by: THERO JOHN F
May 9, 2013 04:12 PM Form 10-Q AMARIN CORP PLC\UK For: Mar 31
May 9, 2013 04:11 PM Form 8-K AMARIN CORP PLC\UK For: May 09
Apr 30, 2013 06:41 AM Form 8-K AMARIN CORP PLC\UK For: Apr 30
Apr 25, 2013 04:24 PM Form 4 AMARIN CORP PLC\UK For: Apr 25 Filed by: Zakrzewski Joseph S
Apr 23, 2013 06:19 AM Form 8-K AMARIN CORP PLC\UK For: Apr 23

Entities mentioned with AMRN